Risk of Metastatic Spread in Patients with Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors

#217

Introduction: The risk of metastatic spread among patients with early-stage surgically resected pancreatic neuroendocrine tumors has not been well-established.

Aim(s): To measure recurrence-free survival (RFS) for patients with resected stage I-III pNETs, stratified by AJCC (American Joint Committee on Cancer) stage.

Materials and methods: Patients with surgically resected non-metastatic pNETs treated at the Moffitt Cancer Center were assigned a stage (I-III) based on the new AJCC classification. Recurrence-free survival was measured for each stage. A separate analysis was performed excluding patients who had been referred to Moffitt Cancer Center after metastatic recurrence.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Strosberg J, Cheema A, Weber J, Kvols L,

Keywords: pancreatic neuroendocrine tumors, AJCC, Stage, Resection,